Subscribe to stay informed!
In the coming days when Endo International closes on its $2.6 billion buyout of the successful men’s health specialty biopharmaceutical company just up…
Chesterbrook specialty biopharmaceutical developer Auxilium Pharmaceuticals Inc. will no longer chase an inversion-inspired merger with Canada’s QLT Inc. now that Endo International, whose…
Endo International said Sept. 30 the firm reached master settlement agreements with several law firms representing leading plantiffs to resolve claims over vaginal mesh products…
Endo International has delivered a proposal to acquire all outstanding shares of Auxilium Pharmaceuticals, a move that would give Auxilium shareholders immediate cash value and…
With the ink still drying on its latest acquisition, former Malvern-based drug maker  Endo International PLC is sending its AMS medical device unit off…
Endo International plc announced Aug. 6 it completed the acquisition of DAVA Pharmaceuticals, Inc., a privately-held company specializing in generic pharmaceuticals.
The purchase price…
Endo International plc is reporting second quarter 2014 revenues of $719 million – up 1 percent over the 2013 $712 million figure.
“Endo delivered strong performance…
Endo International plc, with headquarters in Malvern and Dublin, Ireland, has just acquired Grupo Farmaceutico Somar, a leading, privately owned specialty pharmaceuticals company based in…
Pharmaceutical developer and manufacturer Endo International, which is headquartered in Malvern, agreed to swallow up generic drug maker DAVA Pharmaceuticals, and a spoonful of “meaningful…
Endo International of Malvern and American Medical Systems Inc. have announced they have enrolled their first patient in Embrace, a study focused on treating pelvic…
Before we send you to this site, please subscribe to our daily newsletter.